Susunod

Auto-play

Recent advances in eosinophilia with FGFR rearrangement

1 Mga view • 07/06/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, gives an update on the management of eosinophilia with fibroblast growth factor receptor (FGFR) rearrangement. Encouraging results from the FIGHT-203 study (NCT03011372) evaluating pemigatinib are expected to improve the outcomes of this patient population. This interview took place virtually.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play